Also trades as: 0HB0.L (LSE) · $vol 0M
AGIO NASDAQ
Agios Pharmaceuticals, Inc.
1W: +0.2%
1M: +7.8%
3M: -1.6%
YTD: +5.9%
1Y: -4.6%
3Y: +13.3%
5Y: -47.9%
$28.14
-0.65 (-2.26%)
Weekly Expected Move ±14.0%
$20
$24
$28
$32
$36
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$66M
Revenue
+78.3% YoY
$-423M
Net Income
-163.5% YoY
$-385M
Free Cash Flow
+4.7% YoY
87.1%
Gross Margin
-530.3%
Op. Margin
-477.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-30.9%
ROA-28.6%
ROIC-93.8%
Valuation
P/E-3.9
P/B1.5
EV/EBITDA-2.7
Leverage
Debt/Equity0.05
Current Ratio11.46
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z10.56
Beneish M-1.48